Perceptronix - Early Diagnosis, Better Outcomes

News

March 11, 2016 - Perceptronix Medical Inc. has signed a Memorandum of Understanding with Saree Chan Charity Foundation (China) regarding a purchase of 200 units of Perceptronix’ ClearCyte™ quantitative cytology systems.  The units are to be delivered to the designated cities in China as specified in the final Purchase Agreement to be finalized in June 2016.

November 28, 2015 - Perceptronix Medical Inc. has successfully launched its quantitative cytology system ClearCyte™ in China with installations at the Fourth Military Medical University Xi'jing Hospital in Xi'an and Adicon Clinical Laboratories in Beijing.  The technology, developed at the BC Cancer Agency in partnership with Perceptronix for objective measurement of gross DNA abnormality in cytological preparations has been approved by China Food and Drug Administration in May of 2015.

May 21, 2015 - Perceptronix Medical Inc. has received the approval from China Food and Drug Administration for its core product, ClearCyte™ (v. CWS02-c) digital microscopy workstation for measurement of large-scale DNA abnormality (nuclear DNA content).  The system is intended as an aid to the pathologist in the measurement of normalized DNA content (ploidy) of individual cell nuclei as well as cell populations in cytology preparations of various tissues. Earlier Perceptronix Medical Inc has obtained the cFDA approval for Clear2C staining kit, a consumable product used in quantitative cytology assessment using ClearCyte device.

September 24, 2012 - Perceptronix Announces Publication of Important Clinical Study Evaluating its Oral Cancer Detection Test [HTML]
Perceptronix Medical Inc. (PMI) today announced that positive results from the study evaluating OralAdvance™ quantitative cytology test for early detection of oral cancer are published in the September 2012 issue of Oral Surgery, Oral Pedicine, Oral Pathology and Oral Radiology.

October19, 2010 - PMI Labs Signs First Partnership Deal in the Middle East [HTML]
PMI Labs is excited to announce that it has signed its first Middle Eastern technology partnership deal with Al Mokhtabar Laboratories in Egypt.

October 14, 2010 - PMI Labs Completes Redesign of the Next Generation ClearCyte™ [HTML]
PMI Labs is excited to announce the completion of its next generation ClearCyte™ quantitative cytology platform.

During the past 3 years the Company’s scientific and engineering team has redesigned and reengineered the ClearCyte™ platform to meet more stringent processing and standardization performance measures. As a result of the redesign efforts, per-slide scanning time of the machine has been reduced by more than 65%. This delivers a yearly scanning capacity for each platform of over 40,000 samples. 

November 10, 2009 -PMI Labs Saddened by Loss of Board Member and Great Citizen, Dr. Donald Rix [HTML]
Vancouver, Canada (November 10, 2009) – Dr. Donald Rix, Perceptronix Medical Inc. (“PMI Labs”) Board member and investor, passed away on Friday November 6th, 2009 at the age of 78 following a long illness. He was a truly great citizen of Canada, renowned for his support of the biotechnology industry and for his philanthropy in health, education and the arts.

August 18 , 2009 - PMI Labs Signs LungSign™ Agreement with University of Chile for Regional Lung Cancer Screening Program [HTML]
Vancouver, Canada (August 18, 2009) –PMI Labs (Perceptronix Medical Inc. Laboratories) and University of Chile Faculty of Medicine announce the signing of an agreement focused on implementing PMI Labs’ proprietary quantitative cytology approach of analyzing sputum specimens to complement a lung cancer screening program for high risk individuals in Santiago and in the northern part of Chile (Metropolitan and Antofagasta Regions).

July 27, 2009 - PMI Columbia Labs Signs LungSign™ Agreement with Hong Kong Sanatorium & Hospital for Lung Cancer Screening Program [HTML]
Vancouver, Canada (July 27, 2009) – Perceptronix Medical Inc. Laboratories (PMI Labs) and Hong Kong Sanatorium & Hospital (HKSH), one of the largest private hospitals in Hong Kong, announce the signing of an agreement focused on implementing PMI Labs’ proprietary quantitative cytology approach of analyzing sputum specimens to complement the lung cancer screening program offered by HKSH.

June 4, 2008 - CTV News - British Columbia
"New lung cancer screening test now in Canada" - featured by CTV British Columbia's Dr. Rhonda Low.

May 30, 2008 - Coventry - Midland Newspapers
"Life-saver cancer test launched - Thousands of people in Coventry could get early lung cancer detection, thanks to a pioneering move by the city's superhospital."

November 14 - 20, 2006 - Business in Vancouver - by Daniela Tuchel  [PDF]
"Private Matters - New Perceptronix CEO Carl Roy has jumped from the public sector into private enterprise to help the Vancouver biotech fight cancer and turn a profit in the bargain."

CTV News
CTV News recently featured ClearSign™ buccal in "Your Health with Dr. Rhonda Low."

April 19 - 25, 2005 - Business in Vancouver- by Glenn Drexhage [PDF]

"Vancouver biotechs take aim at lung cancer. Perceptronix Medical Inc. and Protox Therapeutics Inc. look to China and licensing opportunities for their products in the fight against the deadly disease."
 

Media Information

Perceptronix provides accredited journalists with the assistance they need to develop coverage quickly and accurately. We are pleased to coordinate interviews with members of the executive team, to help secure other materials that may assist reporting, and to help fact check information.

For information, please contact:

Perceptronix
Unit 210, 2639 Viking Way,  
Richmond, BC V6V 3B7


Tel: 604.629.8785
Fax: 604.629.8786

Email: info@perceptronix.com 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

News and Events